HK1210951A1 - Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy ullrich - Google Patents

Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy ullrich

Info

Publication number
HK1210951A1
HK1210951A1 HK15111764.4A HK15111764A HK1210951A1 HK 1210951 A1 HK1210951 A1 HK 1210951A1 HK 15111764 A HK15111764 A HK 15111764A HK 1210951 A1 HK1210951 A1 HK 1210951A1
Authority
HK
Hong Kong
Prior art keywords
ullrich
treatment
muscular dystrophy
congenital muscular
immunosuppressive cyclosporin
Prior art date
Application number
HK15111764.4A
Other languages
English (en)
Chinese (zh)
Inventor
保羅．伯納迪
格里哥爾．弗格尼奧克斯
拉斐爾．克萊博
Original Assignee
Debiopharm Int Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm Int Sa filed Critical Debiopharm Int Sa
Publication of HK1210951A1 publication Critical patent/HK1210951A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK15111764.4A 2007-01-04 2010-05-20 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy ullrich HK1210951A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87841407P 2007-01-04 2007-01-04

Publications (1)

Publication Number Publication Date
HK1210951A1 true HK1210951A1 (en) 2016-05-13

Family

ID=39514754

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111764.4A HK1210951A1 (en) 2007-01-04 2010-05-20 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy ullrich

Country Status (12)

Country Link
US (1) US8450281B2 (xx)
EP (1) EP2124992A2 (xx)
JP (1) JP5801534B2 (xx)
CN (2) CN101616683A (xx)
AU (1) AU2008204344B2 (xx)
BR (1) BRPI0806265A2 (xx)
CA (1) CA2674296C (xx)
HK (1) HK1210951A1 (xx)
IL (1) IL199674A (xx)
MX (1) MX2009007045A (xx)
RU (1) RU2462262C2 (xx)
WO (1) WO2008084368A2 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009098533A1 (en) * 2008-02-08 2009-08-13 Debiopharm Sa Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy
WO2011098808A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
EP2533784B1 (en) 2010-02-09 2015-04-22 Neurovive Pharmaceutical AB Sanglifehrin based compounds
WO2011098805A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
GB201008123D0 (en) 2010-05-17 2010-06-30 Biotica Tech Ltd Novel compounds
MX348758B (es) 2010-12-20 2017-06-28 Neurovive Pharmaceutical Ab Derivados de sanglifehrina y metodos para su produccion.
JO3063B1 (ar) 2011-03-29 2017-03-15 Neurovive Pharmaceutical Ab مركب مبتكر وطرق لانتاجه
CN104284671A (zh) 2012-05-07 2015-01-14 诺华股份有限公司 使用阿拉泊韦的药代动力学调节
AR090964A1 (es) 2012-05-09 2014-12-17 Novartis Ag Proceso para la elaboracion de undecapeptidos ciclicos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE95193T1 (de) * 1987-06-17 1993-10-15 Sandoz Ag Cyclosporine und deren benutzung als arzneimittel.
GB2222770B (en) 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
AU3965699A (en) * 1998-04-24 1999-11-16 Mitokor Compounds and methods for treating mitochondria-associated diseases
US6927208B1 (en) * 1998-07-01 2005-08-09 Debiopharm S.A. Cyclosporin with improved activity profile
US6323039B1 (en) * 1999-06-22 2001-11-27 Mitokor Compositions and methods for assaying subcellular conditions and processes using energy transfer
US7368423B1 (en) 2001-12-05 2008-05-06 The Scripps Research Institute Composition and method for treating chronic allograft rejection
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
WO2009098533A1 (en) * 2008-02-08 2009-08-13 Debiopharm Sa Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy

Also Published As

Publication number Publication date
EP2124992A2 (en) 2009-12-02
IL199674A0 (en) 2010-04-15
CA2674296A1 (en) 2008-07-17
AU2008204344B2 (en) 2013-01-31
WO2008084368A8 (en) 2009-09-17
JP5801534B2 (ja) 2015-10-28
IL199674A (en) 2016-10-31
AU2008204344A1 (en) 2008-07-17
CN101616683A (zh) 2009-12-30
RU2462262C2 (ru) 2012-09-27
WO2008084368A9 (en) 2009-02-26
RU2009129212A (ru) 2011-02-10
AU2008204344A9 (en) 2012-06-28
CA2674296C (en) 2015-11-24
MX2009007045A (es) 2009-10-07
CN105056207A (zh) 2015-11-18
WO2008084368A2 (en) 2008-07-17
US8450281B2 (en) 2013-05-28
BRPI0806265A2 (pt) 2011-09-06
US20100041593A1 (en) 2010-02-18
JP2010514834A (ja) 2010-05-06

Similar Documents

Publication Publication Date Title
HK1210951A1 (en) Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy ullrich
IL228598A0 (en) Treatment of Duchenne muscular dystrophy
IL193183A0 (en) Method of treatment for muscular dystrophy
GB0815369D0 (en) Compounds for treatment of duchenne muscular dystrophy
GB0821307D0 (en) Compounds for treatment of duchenne muscular dystrophy
GB0822981D0 (en) Compounds for treatment of duchenne muscular dystrophy
PT2373681T (pt) Composições farmacêuticas de albiglutida
IL193314A0 (en) Treatment of duchenne muscular dystrophy
GB0602768D0 (en) Treatment of muscular dystrophy
IL197966A0 (en) Use of modified cyclosporin
ZA201000225B (en) Treatment of depression
HK1148665A1 (en) Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy
PT2065317E (pt) Método para armazenar embalagens de medicamentos
GB0602767D0 (en) Treatment of muscular dystrophy
GB0809314D0 (en) Compounds for treating muscular dystrophy
GB0619283D0 (en) Treatment of duchenne muscular dystrophy
GB0623983D0 (en) Treatment of duchenne muscular dystrophy
GB0623984D0 (en) Treatment of duchenne muscular dystrophy
GB0617737D0 (en) Treatment of duchenne muscular dystrophy
GB0623985D0 (en) Treatment of duchenne muscular dystrophy
GB0617739D0 (en) Treatment of duchenne muscular dystrophy
GB0617740D0 (en) Treatment of duchenne muscular dystrophy
GB0619281D0 (en) Treatment of duchenne muscular dystrophy
GB0619282D0 (en) Treatment of duchenne muscular dystrophy
IL193707A0 (en) Pro-nanodispersion for the delivery of cyclosporin